471 related articles for article (PubMed ID: 35513871)
1. Interleukin-6 mediated inflammasome activation promotes oral squamous cell carcinoma progression via JAK2/STAT3/Sox4/NLRP3 signaling pathway.
Xiao L; Li X; Cao P; Fei W; Zhou H; Tang N; Liu Y
J Exp Clin Cancer Res; 2022 May; 41(1):166. PubMed ID: 35513871
[TBL] [Abstract][Full Text] [Related]
2. The role of NLRP3 inflammasome in 5-fluorouracil resistance of oral squamous cell carcinoma.
Feng X; Luo Q; Zhang H; Wang H; Chen W; Meng G; Chen F
J Exp Clin Cancer Res; 2017 Jun; 36(1):81. PubMed ID: 28637493
[TBL] [Abstract][Full Text] [Related]
3. Janus Kinase Inhibition Ameliorates Ischemic Stroke Injury and Neuroinflammation Through Reducing NLRP3 Inflammasome Activation
Zhu H; Jian Z; Zhong Y; Ye Y; Zhang Y; Hu X; Pu B; Gu L; Xiong X
Front Immunol; 2021; 12():714943. PubMed ID: 34367186
[TBL] [Abstract][Full Text] [Related]
4. CCL18-NIR1 promotes oral cancer cell growth and metastasis by activating the JAK2/STAT3 signaling pathway.
Jiang X; Huang Z; Sun X; Zheng X; Liu J; Shen J; Jia B; Luo H; Mai Z; Chen G; Zhao J
BMC Cancer; 2020 Jul; 20(1):632. PubMed ID: 32641093
[TBL] [Abstract][Full Text] [Related]
5. NLRP3 promotes tumor growth and metastasis in human oral squamous cell carcinoma.
Wang H; Luo Q; Feng X; Zhang R; Li J; Chen F
BMC Cancer; 2018 May; 18(1):500. PubMed ID: 29716544
[TBL] [Abstract][Full Text] [Related]
6. Epiregulin reprograms cancer-associated fibroblasts and facilitates oral squamous cell carcinoma invasion via JAK2-STAT3 pathway.
Wang Y; Jing Y; Ding L; Zhang X; Song Y; Chen S; Zhao X; Huang X; Pu Y; Wang Z; Ni Y; Hu Q
J Exp Clin Cancer Res; 2019 Jun; 38(1):274. PubMed ID: 31234944
[TBL] [Abstract][Full Text] [Related]
7. SOX4 expression is associated with treatment failure and chemoradioresistance in oral squamous cell carcinoma.
Yoon TM; Kim SA; Cho WS; Lee DH; Lee JK; Park YL; Lee KH; Lee JH; Kweon SS; Chung IJ; Lim SC; Joo YE
BMC Cancer; 2015 Nov; 15():888. PubMed ID: 26555193
[TBL] [Abstract][Full Text] [Related]
8. JAK2 regulation by licochalcone H inhibits the cell growth and induces apoptosis in oral squamous cell carcinoma.
Oh HN; Oh KB; Lee MH; Seo JH; Kim E; Yoon G; Cho SS; Cho YS; Choi HW; Chae JI; Shim JH
Phytomedicine; 2019 Jan; 52():60-69. PubMed ID: 30599913
[TBL] [Abstract][Full Text] [Related]
9. Chemerin promotes invasion of oral squamous cell carcinoma by stimulating IL-6 and TNF-α production via STAT3 activation.
Lu Z; Liu J; Wan Q; Wu Y; Wu W; Chen Y
Mol Biol Rep; 2024 Mar; 51(1):436. PubMed ID: 38520551
[TBL] [Abstract][Full Text] [Related]
10. NLRP3 inflammasome activation promotes inflammation-induced carcinogenesis in head and neck squamous cell carcinoma.
Huang CF; Chen L; Li YC; Wu L; Yu GT; Zhang WF; Sun ZJ
J Exp Clin Cancer Res; 2017 Sep; 36(1):116. PubMed ID: 28865486
[TBL] [Abstract][Full Text] [Related]
11. Simiao San alleviates hyperuricemia and kidney inflammation by inhibiting NLRP3 inflammasome and JAK2/STAT3 signaling in hyperuricemia mice.
Zhang Y; Wang S; Dai X; Liu T; Liu Y; Shi H; Yin J; Xu T; Zhang Y; Zhao D; Sukhorukov V; Orekhov AN; Gao S; Wang L; Zhang D
J Ethnopharmacol; 2023 Aug; 312():116530. PubMed ID: 37098372
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA‑199a‑5p suppresses migration and invasion in oral squamous cell carcinoma through inhibiting the EMT‑related transcription factor SOX4.
Wei D; Wang W; Shen B; Zhou Y; Yang X; Lu G; Yang J; Shao Y
Int J Mol Med; 2019 Jul; 44(1):185-195. PubMed ID: 31059001
[TBL] [Abstract][Full Text] [Related]
13. NLRP3 Inflammasome Inhibitor BAY-117082 Reduces Oral Squamous Cell Carcinoma Progression.
Scuderi SA; Casili G; Basilotta R; Lanza M; Filippone A; Raciti G; Puliafito I; Colarossi L; Esposito E; Paterniti I
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681768
[TBL] [Abstract][Full Text] [Related]
14. IL-1RA promotes oral squamous cell carcinoma malignancy through mitochondrial metabolism-mediated EGFR/JNK/SOX2 pathway.
Yuan SF; Wang YM; Chan LP; Hung AC; Nguyen HDH; Chen YK; Hu SC; Lo S; Wang YY
J Transl Med; 2023 Jul; 21(1):473. PubMed ID: 37461111
[TBL] [Abstract][Full Text] [Related]
15. SOX12 contributes to the activation of the JAK2/STAT3 pathway and malignant transformation of esophageal squamous cell carcinoma.
Li C; Zhu M; Zhu J; Lu Q; Shi B; Sun B; Chen H
Oncol Rep; 2021 Jan; 45(1):129-138. PubMed ID: 33416144
[TBL] [Abstract][Full Text] [Related]
16. STAT3-induced upregulation of long noncoding RNA HNF1A-AS1 promotes the progression of oral squamous cell carcinoma via activating Notch signaling pathway.
Liu Z; Li H; Fan S; Lin H; Lian W
Cancer Biol Ther; 2019; 20(4):444-453. PubMed ID: 30404566
[TBL] [Abstract][Full Text] [Related]
17. CCL21/CCR7 interaction promotes EMT and enhances the stemness of OSCC via a JAK2/STAT3 signaling pathway.
Chen Y; Shao Z; Jiang E; Zhou X; Wang L; Wang H; Luo X; Chen Q; Liu K; Shang Z
J Cell Physiol; 2020 Sep; 235(9):5995-6009. PubMed ID: 32017846
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of miR-133b indicates poor prognosis and promotes progression of OSCC via SOX4.
Yang J; Wang H; Xu W; Chen Z; Yan ZY; Zhang LJ
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12717-12726. PubMed ID: 33378019
[TBL] [Abstract][Full Text] [Related]
19. p53-targeted lincRNA-p21 acts as a tumor suppressor by inhibiting JAK2/STAT3 signaling pathways in head and neck squamous cell carcinoma.
Jin S; Yang X; Li J; Yang W; Ma H; Zhang Z
Mol Cancer; 2019 Mar; 18(1):38. PubMed ID: 30857539
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol ameliorates glioblastoma inflammatory response by reducing NLRP3 inflammasome activation through inhibition of the JAK2/STAT3 pathway.
Zhang C; Peng Q; Tang Y; Wang C; Wang S; Yu D; Hou S; Wang Y; Zhang L; Lin N
J Cancer Res Clin Oncol; 2024 Mar; 150(3):168. PubMed ID: 38546908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]